3Hokama JY, Ritter KS, Davis-Gorman G, et al. Diabetes enhances leukocyte accumulation in the coronary microcirculation early in reperfusion following ischemia[ J]. J Diabetes Complications, 2000,14( 1 ) : 94-107.
4Tailor A, Granger DN. Role of adhesion molecules in vascular regulation and damage[J]. Curr Hypertens Rep,2000,2( 1 ) :78-83.
5Osende JI, Badimon J J, Fuster V, et al. Blood thrombogenicity in type 2 diabetes mellitus patients is associated with glycemic control[J]. J Am Coil Cardiol,2001,38(5) : 1307-1312.
6Vinik AI, Erbas T, Park TS, et al. Platelet dysfunction in type 2 diabetes[J]. Diabetes Care,2001,24(8) : 1476-1485.
7Bierhaus A, Illmer T, Kasper M, et al. Advanced glycation endproducts(AGE)-mediated induction of tissue factor in cultured endothelial cells is dependent on RAGE[J]. Circulation, 1997,96(7) :2262-2271.
8Park L, Raman KG, Lee KJ, et al. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts[ J]. Nat Med, 1998,4(9) : 1025-1031.
10Ahn CW, Lee HC, Park SW. Decrease in carotid intima media thickness after 1 year of eilostazol treatment in patients with type 2 diabetes mellitus[ J]. Diabetes Res Clin Pratt,2001,52( 1 ) :45-53.
8Standl E,Schnell O. A look at the heart in diabetesmellitus: fram ail-ing to failing[J]. Diahetolia ,2300,43(12) :1435-1469.
9Akalin A,Temiz G,Akcar N,et al. Short term effects of ator- vastatinon endothelial functions and oxidized LDL levels in pa- tientswith type 2 diabetes[J]. Endocr J, 2008,55 (5) : 861-866.
10Lundstrtim A1 ,Laska AC,Von Arbin M,et al. Glucose intoler- ance and insulin resistance as predictors of low platelet response to clopidogrel in patients with minor ischcmic stroke or TIA[J]. Platelets,2014,25(2) : 102-110.
